POSTED: December 12, 2014

The editors of CEO/CFO Magazine went one-on-one with Zocere CEO Wayne Laslie for an inside look at the company neuroprotectant drug candidate for stroke, its market potential, commercialization strategy, and an update on fundraising. Read the article>